WebMD Announces Exploration Of Strategic Alternatives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall St inches lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil slides on clues about Fed policy, rumors of Hormuz deal
- Dollar rises to session high after Warsh comments, set for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- BioNTech ends colorectal cancer mRNA therapy trial early
- Ovintiv adds 41,000 acres in Permian and Montney deals
WebMD (WBMD) PT Raised to $55 at Mizuho Securities Following 4Q Results, Strategic Options
February 17, 2017 5:45 AM ESTMizuho analyst Neil Doshi reiterates Neutral rating and raises price target on WebMd Health Corp. (NASDAQ: WBMD) to $55 (from $52), noting a disappointing outlook and back-end loaded growth, as the company reported 2016 fourth quarter results in-line with estimates, while exploring strategic alternatives.
Doshi... More
WebMD Health (WBMD) Tops Q4 EPS by 7c; Guides Q1, FY17 Revs Below Views
February 16, 2017 4:04 PM ESTWebMD Health (NASDAQ: WBMD) reported Q4 EPS of $0.73, $0.07 better than the analyst estimate of $0.66. Revenue for the quarter came in at $207.5 million versus the consensus estimate of $206.99 million.
GUIDANCE:
WebMD Health sees Q1 revs of $151 million to $154 million versus the... More
